#EAPCI /PCR Journal Club:
PCI versus #CABG in patients with left main disease with and without #diabetes

➡️pcronline.com/PCR-Publicatio…

Antonio Colombo and Alessandro Sticchi review ✍️ this pooled analysis of 4 RCTs that shows that diabetic patients undergoing revascularization face…

tra 2 giorni l'imperdibile webinar del GDS Cardiopatie valvolari sul trattamento delle valvulopatie. Sono le correnti linee guida già obsolete? Rispondono a questa domanda Philippe Pibarot, Rebecca Hahn, Maurice Sarano e Patricia Pellika. What else?

A+ #TAVR explant lecture by @PhilippKieferMD von und für Leipzig - not official❤️ #TVI2024 🇧🇷on risk zone classification across TAV types in difficulty. Mateo Marín-Cuartas EduardoSaadi vinayak bapat Edwin Ho Tsuyoshi Kaneko Isaac George MD AATS The Society of Thoracic Surgeons EACTS

🚨 #EAPCIJournalClub is coming🚨
🎯Discussed trial:
➡️ORBITA-2 (bit.ly/NEJM-Orbita2)

🗓️23 April
⏰18:00 CEST

With:
Dr. Lena Seegers
Rasha Al-Lamee
Ignacio Cigalini 🇦🇷
Erik Rafflenbeul

‼️Register here‼️
🔗esc365.escardio.org/event/1606

#ByTheFellows #ForTheFellows

Complete revascularization is now 'a must' in ACS, but the optimal timing remains a matter of controversy: immediate? Staged in-hospital? Staged within 45 days? Staged when you want?

This prespecified analysis of the randomized BIOVASC trial suggests that immediate complete…

Kudos to all Journal Club Channel & Sici GISE young team that created and worked in the project.

Thankful to EAPCIPresident chief Erik Rafflenbeul for their vision & support 🙏

Join #EAPCI Journal club ep. 4!!🔗 esc365.escardio.org/event/1606

Vulnerable plaque #ClinicalCorner Sici GISE

Stent or not stent? 🤔

Great OCT based discussion with
Francesco Bruno giulia masiero Rocco Vergallo

Delighted to bring our EAPCI Journal club to 🇬🇧

Discussing #ORBITA2 and the fantastic work by the team:

Rasha Al-Lamee Christopher Rajkumar Michael Foley Fiyyaz Ahmed-Jushuf Florentina Simader Prof Darrel Francis ☺ Mk CardioFellows Great Again

Nice Review of SMR Phenotypes bit.ly/MVPheno_TEER and OMT for SMR: bit.ly/OMT_FMR Paul Grayburn Anna Sannino MD PhD FASE jörg hausleiter Ulrich Jorde JACC Journals Circulation

Friday ⏱️7:30 at the #ClinicalCorner a case-based discussion on:

➡️ #imagingfirst
➡️ #OCT in Vulnerable plaque
➡️Prevent RCT The Lancet

Check the QR code for the topic overview

🔗GISE news letter or DM

🎙Second episode of the #ClinicalCorner is coming!

🔥 Topic #imaging challenges: dealing with a vulnerable plaque

👥 Engage with a clinical case on cutting-edge science with Francesco Bruno, @roccovergallo and giulia masiero

GISE Young’s #CScorner kicked off last week discussing #TAVIchallenges in small annuli!

No worries if you missed it, it’s available at the links below 👇
gise.it/notizie/ordina…
youtube.com/watch?v=zg7P_Y…
Sici GISE Francesco Saia federica serino Marco Toselli

New JACC Journals SOTA on TR Management Pre-TTVI. bit.ly/3VMKtao also see:
bit.ly/TVARC Mack Eleid Joann Lindenfeld jörg hausleiter Philipp Lurz

Deep Dive Slides #ACC2024 on SMART Trial. William Suh, MD Philippe Pibarot Amr Abbas thomas modine David J. Cohen, MD, MSc Mamas A. Mamas Dipti Itchhaporia, M.D., MACC , FAHA, FESC Athena Poppas, MD FACC NL valve w/ high gradient is NOT “dysfunction”-may be high EF! BEV EchoGradient > but CathGrad < SEV! MGrad and PPM not predictive!!

#ACC24 : PREVENT

A.Nazmi Calik reviews ✍️ this trial that sought to assess the impact of preventive PCI on major adverse cardiovascular events among patients presenting with high-risk, non-flow-limiting vulnerable plaques identified through intracoronary ⭕️ imaging.…

There is a lot of interest around small aortic annulus after SMART NEJM &OperaTAVI JACC Journals

⬇️For a stepwise management:
Sici GISE #ClinicalCorner Ep.1-TAVI Challenges: small aortic annulus & hostile youtu.be/zg7P_YdZT7U?si…

federica serino Antonio Sorropago Francesco Saia

Congrats to Danger team Christian Hassager! Impressive results, now after SHOCK and Culprit-Shock 3rd positive RCT. Nevertheless, multiple questions remain: 1) is it the device? 2) patient selection? 3) treatment bias? 4) longer follow-up? Sean van Diepen Johann Bauersachs Navin Kapur

ULTIMATE-DAPT results presented at #ACC24

SMART trial presented with no surprises. nejm.org/doi/full/10.10… NEJM American College of Cardiology #ACC2024

After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone.

The…